Skip to main content


The 2019 report for the program is now available.

Annual reports on the information collected by the program and any recommendations for legislative changes to contain the cost or reduce the effect of prescription drugs will be available every year in December.

2019 Prescription Drug Price Transparency – Results and Recommendations

The department has started learning several things about prescription drugs in the first year of reporting, such as how the U.S. list price compares to prices in other countries, drugs that are the most costly for health insurers, and what drugs are of most concern to Oregonians. This report is based on all data, not claimed to be a trade secret, submitted as of November 2019.

View 2019 Report Here

Summer 2019 Common Ground Newsletter

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how